JNJ News Alert Johnson & Johnson (JNJ) 103.28 01/06/2015 17:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Johnson & Johnson (JNJ) 103.28 $JNJ

Final Glance: Pharmaceuticals companies
AP - 53 mins ago
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 103.28 (-0.51), BAX: 71.11 (-0.38), PFE: 31.42 (+0.26), BMY: 58.48 (-0.10)

Final Glance: Medical Devices companies
AP - 53 mins ago
NEW YORK (AP) — Shares of some top medical devices companies were down at the close of trading:
ZMH: 115.80 (-0.99), JNJ: 103.28 (-0.51), MDT: 71.22 (-0.36), BAX: 71.11 (-0.38)

Pharmacyclics Reports Encouraging Data on Cancer Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 1 hr 12 mins ago
Pharmacyclics, Inc. (PCYC) announced encouraging data on its oncology drug, Imbruvica.
AGN: 209.37 (-2.06), JNJ: 103.28 (-0.51), PCYC: 119.85 (-0.12), ABBV: 64.33 (-0.32)

AOL and Gilead Sciences are big market movers
AP - 27 mins ago
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
F: 14.62 (-0.14), K.TO: 3.95 (+0.47), CS: 23.81 (-0.43), BBEP: 6.90 (+0.08), SDRL: 10.48 (-0.33), NBG: 1.58 (-0.08), CYBX: 54.36 (-3.43), JNJ: 103.28 (-0.51), ISIS: 65.44 (-2.73), KGC: 3.33 (+0.38), AOL: 46.25 (+1.51), CVEO: 3.11 (-0.32), EBIX: 18.60 (+2.32), THLD: 3.55 (-0.13), CEMP: 23.15 (-1.40), VZ: 47.04 (+0.47), XOOM: 16.82 (-0.07)

Isis Pharmaceuticals Up on Collaboration with J&J - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 37 mins ago
Isis Pharmaceuticals (ISIS) inked a global collaboration with Johnson & Johnson's (JNJ) Janssen Biotech, Inc for the discovery and development of antisense drugs for treating autoimmune disorders of the gastrointestinal tract.
BIIB: 334.65 (-2.09), JNJ: 103.28 (-0.51), ISIS: 65.44 (-2.73), AZN: 68.16 (-1.70)

Johnson & Johnson begins Ebola vaccine testing in humans
AP - Tue Jan 06, 2:27PM CST
NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson has begun testing an Ebola vaccine in humans intended to counter a strain of the virus similar to the one that has wreaked havoc in West Africa.
JNJ: 103.28 (-0.51)

Selling Guidelines For Self Directed Investors
Chowder - at Seeking Alpha - Tue Jan 06, 2:13PM CST

HYH: 45.65 (+0.88), ABT: 44.40 (-0.51), FTR: 6.44 (-0.06), MDLZ: 35.99 (-0.25), DUK: 84.20 (+1.36), NUE: 46.46 (-0.68), ED: 66.08 (+0.37), KMB: 113.78 (-1.11), KRFT: 61.86 (+0.01), SDRL: 10.48 (-0.33), HCBK: 9.56 (-0.20), WM: 51.27 (+0.04), DRI: 58.19 (+0.20), JNJ: 103.28 (-0.51), CDK: 39.71 (-0.11), ADP: 82.54 (-0.69), LNCO: 11.31 (+0.09), TOO: 23.95 (-0.07), BP: 35.83 (-0.27), ABBV: 64.33 (-0.32), PG: 89.60 (-0.41), GIS: 52.02 (-0.13), CTL: 38.27 (-0.48)

Midday Glance: Pharmaceuticals companies
AP - Tue Jan 06, 12:17PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 103.28 (-0.51), BAX: 71.11 (-0.38), PFE: 31.42 (+0.26), BMY: 58.48 (-0.10)

Midday Glance: Medical Devices companies
AP - Tue Jan 06, 12:17PM CST
NEW YORK (AP) — Shares of some top medical devices companies are down at 1 p.m.:
ZMH: 115.80 (-0.99), JNJ: 103.28 (-0.51), MDT: 71.22 (-0.36), BAX: 71.11 (-0.38)

Why Biogen Idec Inc. Stock Catapulted 10% Higher in December
Sean Williams, The Motley Fool - Motley Fool - Tue Jan 06, 10:31AM CST
What: Shares of Biogen Idec , a biotech juggernaut primarily focused on treating multiple sclerosis and autoimmune disorders, scorched higher by 10% in December, based on data from S&P Capital IQ , on the heels of positive clinical data...
JNJ: 103.28 (-0.51), BIIB: 334.65 (-2.09), PFE: 31.42 (+0.26), DB: 28.36 (-0.46), LLY: 69.72 (+0.35)

Stocks Turn Lower as 'Structural Flaws' in Global Economy Surface
at The Street - Tue Jan 06, 10:10AM CST
Stocks turn lower after Monday's broad selloff.
YHOO: 49.21 (+0.08), JNJ: 103.28 (-0.51), COH: 36.30 (-0.43), WBA: 74.69 (+0.19), AOL: 46.25 (+1.51), VZ: 47.04 (+0.47)

Early Glance: Pharmaceuticals companies
AP - Tue Jan 06, 9:37AM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are up at 10 a.m.:
JNJ: 103.28 (-0.51), BAX: 71.11 (-0.38), PFE: 31.42 (+0.26), BMY: 58.48 (-0.10)

Early Glance: Medical Devices companies
AP - Tue Jan 06, 9:37AM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 115.80 (-0.99), JNJ: 103.28 (-0.51), MDT: 71.22 (-0.36), BAX: 71.11 (-0.38)

Watch for Shares of Johnson & Johnson (JNJ) to Approach Resistance at $105.12
Comtex SmarTrend(R) - Tue Jan 06, 9:31AM CST
Johnson & Johnson (NYSE:JNJ) has opened bullishly above the pivot of $104.07 today and has reached the first level of resistance at $104.45. Should the shares continue to rise, the resistance pivots of $105.12 and $106.16 will be of interest.
JNJ: 103.28 (-0.51)

Company News for January 06, 2015 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Tue Jan 06, 9:10AM CST
Companies in the News are: KITE,AMGN,STI,ISIS,NPSP,GS
JNJ: 103.28 (-0.51), GS: 184.53 (-3.81), ISIS: 65.44 (-2.73), KITE: 71.45 (+1.70), NPSP: 41.05 (+2.92), STI: 39.08 (-1.16), AMGN: 152.90 (-5.09)

Johnson & Johnson Dividend Stock Analysis
Roadmap2Retire - at Seeking Alpha - Tue Jan 06, 8:19AM CST

JNJ: 103.28 (-0.51)

My Income Portfolio Quarterly Update (Q4 2014)
Invest Yourself - at Seeking Alpha - Tue Jan 06, 8:13AM CST

AMLP: 16.95 (-0.23), GE: 24.07 (-0.53), MAIN: 28.34 (-0.80), HSY: 103.32 (+0.34), WMT: 86.31 (+0.66), AWK: 53.25 (+0.14), O: 50.27 (+0.65), INTC: 35.28 (-0.67), PEP: 93.02 (-0.71), JNJ: 103.28 (-0.51), DE: 85.73 (-0.72), WY: 36.07 (-0.04), DD: 70.89 (-0.83), LTC: 45.00 (+0.44), CSCO: 27.05 (-0.01), NSC: 103.00 (-3.39), HYD: 31.10 (+0.07), WFC: 52.09 (-1.11), PGX: 14.73 (+0.01), SO: 49.75 (+0.59), WM: 51.27 (+0.04), DRI: 58.19 (+0.20), ADM: 49.23 (-0.99), CVX: 108.03 (-0.05), AFL: 58.95 (-0.53)

Stock Futures Slip Into Red as Crude Oil Rout Continues
at The Street - Tue Jan 06, 7:58AM CST
Stock futures turn lower on Tuesday, triggered by a selloff of crude oil.
YHOO: 49.21 (+0.08), JNJ: 103.28 (-0.51), AOL: 46.25 (+1.51), AAL: 53.04 (-0.84), JBLU: 14.97 (-0.25), VZ: 47.04 (+0.47), LUV: 40.46 (-1.18)

Johnson & Johnson Announces Start of Phase 1 Clinical Trial of Ebola Vaccine Regimen
PR Newswire Europe - Tue Jan 06, 6:51AM CST
- Company Has Produced More Than 400,000 Vaccine Regimens for Use in Large-Scale Clinical Trials by April 2015
JNJ: 103.28 (-0.51)

J&J begins Ebola vaccine trial in U.K.
Seeking Alpha - at Seeking Alpha - Tue Jan 06, 3:07AM CST

JNJ: 103.28 (-0.51)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

How Timekettle Is Bridging Language Gaps at IFA 2026

Updated Category News Views 1

Pioneering AI Innovations in Language Translation Timekettle is making some serious waves at IFA 2026, throwing its hat in the ring with innovations that redefine multilingual interaction. From sleek translation earbuds to full-blown meeting hubs, each gadget screams one thing loud and clear—communication sans language barriers. Centered in the tech extravaganza of...

Continue Reading
Reliable Safety & Flow: A New Era in Infrastructure

Updated Category News Views 3

Seismic Merger: Reliable Sprinkler and ASC Join Forces When two companies with roots stretching back to the 1800s decide to merge, it's not just a business move—it's a bold statement. Reliable Automatic Sprinkler and ASC Engineered Solutions, with over 175 years of combined innovation, have officially become Reliable Safety & Flow Corporation. This ain't just a...

Continue Reading
Stoke Space Raises $1B; XTEND AI Hits NYSE

Updated Category News Views 1

A Billion-Dollar Boost for Stoke Space Ever catch wind of a company hauling in a cool billion and shrug it off? Me neither. Stoke Space Technologies just locked down $1 billion in Series E funding. This ain't some pocket change—the kind of dough you need when you're eyeing stars and plotting orbital voyages. They're gearing up for a 2027 mission with their Nova...

Continue Reading
WaFd and EverBank $3.9B Deal Spurs Big Bank Shift

Updated Category News Views 4

Remember the good old days when banking was just about collecting interest? Now it's all about combining forces to bolster strength, and that's just what we're seeing with WaFd, Inc. (NASDAQ: WAFD) and EverBank Financial Corp flipping the script and shaking hands on a $3.9 billion reverse merger. Strategic Vision: A New Chapter They're calling it a 'strategic...

Continue Reading
Drunk Angel Celebrates First Year in Crystal Jewelry

Updated Category News Views 2

One Year Down, A Unique Path Forward It's been a year since Drunk Angel jumped into the online jewelry scene, and they're setting themselves apart in their own glittery lane. Imagine starting a brand that's not just about pretty trinkets, but about linking those tiny treasures to timeless traditions. They've got their sights set on blending the deep tales of gemstones...

Continue Reading
West Texas Weather Shapes Home Design Decisions

Updated Category News Views 2

West Texas Weather: A Tough Customer for Home Builders You'd think building a house is a straightforward gig, but slap it down in West Texas, and we're talking a whole different ballgame. With its brutal heat, howling winds, and wild temperature swings, Odessa isn't just painting by numbers. It's where Mother Nature is your uninvited consultant on every single...

Continue Reading
Austin PostalAnnex Changes Hands After 19 Years

Updated Category News Views 2

A Seamless Transition in Austin's PostalAnnex Legacy You know when a business digs its roots deep, becoming more than just a place but a part of the community fabric? That's what’s playing out at the PostalAnnex on W Parmer Lane, Austin. After nearly two decades, this battered yet steadfast hub of office and shipping services is swapping hands, all in the name of...

Continue Reading
Jollibee and DreamWorks Unite for Cultural Celebration

Updated Category News Views 2

Jollibee Partners with DreamWorks Animation Never thought I’d see the day: Jollibee, that familiar face of fast food, teaming up with the creative juggernaut DreamWorks Animation. They’re calling it a celebration of friendship and Filipino culture, wrapped up neatly in the context of a flick called Forgotten Island. Set to sizzle in theaters on September 25, 2026,...

Continue Reading
Nashville Benefit Concert Supports Animal Rescue Mission

Updated Category News Views 2

Country Tunes and Compassion Unite for Rescue Efforts There's something electric about a community banding together, especially when it's through the warmth of country music and the noble mission of animal rescue. Animal Rescue Corps (ARC), meeting ground for art and heart, is turning the Nashville Palace into a sanctuary not just for music, but for hope. They've got...

Continue Reading
ASCEND® Cladding Unveils New Profiles & Texture Variety

Updated Category News Views 0

New Options for Creative Home Exteriors Amid today's housing market rollercoaster, a sprinkle of bold innovation in building materials can make a statement—and that's precisely what Associated Materials Innovations (AMI) is banking on with their latest beef-up in the ASCEND® Composite Cladding lineup. Introduced out of Cuyahoga Falls on Sept. 8, 2026, this expansion...

Continue Reading

Top 5 Most Recently Viewed Articles

RIBER Expands GaN Production With New MBE 49 System Order

Updated Category News Views 69

RIBER Expands GaN Production Capabilities RIBER, a prominent player in the field of molecular beam epitaxy (MBE) systems, has successfully secured an order for their cutting-edge MBE 49 GaN system from a European manufacturer. This strategic acquisition is pivotal for the client's objective to bolster the production capacity of advanced gallium nitride (GaN) components,...

Continue Reading
Investing Insights: Five Key Stocks Captivating Attention

Updated Category News Views 211

Market Overview Recently, U.S. stocks showed a positive bounce, with the Dow Jones index rising by over 190 points, marking an increase of 0.4%. Similarly, both the S&P 500 and the Nasdaq followed suit, climbing approximately 0.3% and 0.1% respectively. This surge in the market reflects improved investor sentiment as highlighted by shifts in various market indices. This...

Continue Reading
Immutep Secures Significant R&D Incentive from French Authorities

Updated Category News Views 111

Immutep Receives Significant R&D Tax Incentive Immutep Limited (ASX: IMM; NASDAQ: IMMP), an innovative biotechnology company, is proud to announce a remarkable achievement in securing a substantial research and development tax incentive from the French government. This financial support totals €2,588,954, which is approximately A$4,567,769. This incentive is granted...

Continue Reading
Rasmal Ventures Launches First Fund with QIA's Support

Updated Category News Views 271

Rasmal Ventures Unveils Pioneering VC Fund Rasmal Ventures has made waves in the venture capital scene by launching Rasmal Innovation Fund I LLC, marking it as the inaugural fund under QIA’s substantial Fund of Funds initiative, aimed at fostering a vibrant investment landscape. Driving Innovation in the MENA Region This venture capital fund aspires to ignite innovation...

Continue Reading
Connect Biopharma Faces Nasdaq Deficiency Yet Eyes Recovery

Updated Category News Views 144

Understanding the Nasdaq Deficiency Notice Received by Connect Biopharma Connect Biopharma Holdings Limited (NASDAQ: CNTB), a prominent clinical-stage biopharmaceutical company, recently found itself in a situation that many companies face on the stock market. The Company received a notification from the Listings Qualifications Department of the Nasdaq Stock Market...

Continue Reading